ArticleScientific reports2026
Sex and BMI as predictors of pill residue in dysphagia: a multivariate analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
We aimed to explore the specific challenges encountered by individuals with dysphagia when taking oral medications, focusing on the types of dysphagia that impede pill swallowing and the relationship between body mass index (BMI) and pill residue. We retrospectively reviewed 70 patients who underwent videofluoroscopic swallowing studies at the Department of Dysphagia Rehabilitation, Tokyo Medical and Dental University Dental Hospital between May 2013 and March 2020. Patients were assessed for pill residue in various anatomical locations, including the mouth, epiglottic vallecula, and piriform sinus. Patient demographics, BMI, functional oral intake scale scores, and clinical histories were collected. Pill residue was most commonly observed in the epiglottic vallecula (17% of patients), followed by the piriform sinus (10%) and mouth (9%). Males were more likely to have tablet residue in the epiglottic vallecula (p = 0.047), and a lower BMI was associated with increased pill residue in the piriform sinus (p = 0.025). Multivariate analysis identified sex as a significant predictor of epiglottic pill residue (p = 0.031), whereas a lower BMI was associated with pill residue in the piriform sinus (p = 0.016). Sex and BMI significantly influenced pill residue in patients with dysphagia; males and individuals with a lower BMI (< 18.5 kg/m2) were at higher risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.